Table 2.
Characteristics of study patients (N=82).
| Characteristic | n (%) | |
| Age (years) | ||
|
|
18-30 | 2 (2%) |
|
|
31-40 | 7 (9%) |
|
|
41-50 | 12 (15%) |
|
|
51-60 | 29 (35%) |
|
|
61-70 | 22 (27%) |
|
|
>70 | 10 (12%) |
| Gender | ||
|
|
Men | 46 (56%) |
|
|
Women | 36 (44%) |
| Primary cancer localization | ||
|
|
Lung | 34 (41%) |
|
|
Lymphoma | 12 (15%) |
|
|
Skin | 12 (15%) |
|
|
Kidney | 5 (6%) |
|
|
Prostate | 3 (4%) |
|
|
Ovarian | 3 (4%) |
|
|
Leukemia | 3 (4%) |
|
|
Othera | 10 (12%) |
| Time since cancer diagnosis | ||
|
|
0-5 years | 65 (79%) |
|
|
6-10 years | 10 (12%) |
|
|
>10 years | 6 (7%) |
|
|
Do not know | 1 (1%) |
| Place of treatment in previous 12 monthsb | ||
|
|
University hospital | 28 (34%) |
|
|
Local hospital | 27 (33%) |
|
|
Private clinic | 25 (30%) |
|
|
Specialist cancer center | 14 (17%) |
|
|
Community medical center | 4 (5%) |
|
|
Not treated in previous 12 months | 1 (1%) |
aHead and neck, multiple myeloma, and bladder cancer: 2 cases each; colon, liver, cervical, and bladder/prostate cancer: 1 case each.
bMultiple responses were possible.